Impact of immunosuppressive regimens on antibody response after COVID-19 vaccination among Thai kidney transplant recipients

Impact of immunosuppressive regimens on antibody response after COVID-19 vaccination among Thai kidney transplant recipients

Background: The lower humoral immunity response after the COVID-19 vaccine in kidney transplant recipients (KTR) has been reported in several studies. However, there are few studies on the efficacy of the ChAdOx1 nCoV-19 (AstraZeneca) vaccine compared between various immunosuppressive regimens. Meth...

Full description

Saved in:

Bibliographic Details
Main Authors:	Nuttasith Larpparisuth, Kritsada Pongsakornkullachart, Nartsiri Ratchawang, Attapong Vongwiwatana, Peenida Skulratanasak
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Heliyon
Subjects:	SARS-CoV-2 COVID-19 Kidney transplantation ChAdOx1 nCoV-19 vaccine Anti-Spike RBD IgG
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844025006711
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Is The SARS-CoV2 Evolved in Human Being: A prospective Genetic Analysis
by: Salvatore Dimonte, et al.
Published: (2020-12-01)

Coronil effectively inhibits the interaction of clinically relevant Omicron mutants of SARS-CoV-2 spike proteins with human ACE2 receptor
by: Acharya Balkrishna, et al.
Published: (2025-02-01)

Tracking of The Most Significant Laboratory Parameters For The Identification of Covid-19: An Overview on The Different Blood Tests
by: Seenaa Ali
Published: (2020-06-01)

Tracking Immunity: An Increased Number of COVID-19 Boosters Increases the Longevity of Anti-RBD and Anti-RBD-Neutralizing Antibodies
by: Ching-Wen Hou, et al.
Published: (2025-01-01)

An Overview on The Pandemic Coronavirus Disease 2019 (COVID-19) Outbreak
by: Mariwan Abdulla Hama Salih
Published: (2020-05-01)

Adherence to vaccination against SARS-CoV-2 and vaccine safety in patients with immunoglobulin G4-related disease
by: Linda Mastromanno, et al.
Published: (2025-01-01)

Comparison of IgG and Neutralizing Antibody Response After Pfizer BioNTech COVID-19 Vaccine Among Iraqi Individuals
by: Najat Saeed Hussein, et al.
Published: (2023-06-01)

Heterologous vaccination with subunit protein vaccine induces a superior neutralizing capacity against BA.4/5‐included SARS‐CoV‐2 variants than homologous vaccination of mRNA vaccine
by: Dandan Peng, et al.
Published: (2023-04-01)

Bee Venom—A Potential Complementary Medicine Candidate for SARS-CoV-2 Infections
by: Keneth Iceland, Kasozi, et al.
Published: (2021)

Combined mutations in nonstructural protein 14, envelope, and membrane proteins mitigate the neuropathogenicity of SARS-CoV-2 Omicron BA.1 in K18-hACE2 mice
by: Kotou Sangare, et al.
Published: (2025-01-01)

COVID-19 – a new challenge for the medical community
by: D. Valančius, et al.
Published: (2020-06-01)

The disappearing COVID-Naïve Population and comparative Roche vs. Abbott Test sensitivity: evidence from antibody seroprevalence in Milwaukee County, Wisconsin
by: Lorenzo Franchi, et al.
Published: (2024-11-01)

A Letter to Reconsider the Conditions for Testing Decontaminated N95 Respirators for Emergency Reuse to Address Shortage
by: Eric P. Vejerano, et al.
Published: (2024-12-01)

COVID-19 Lockdowns Improve Air Quality in the South-East Asian Regions, as Seen by the Remote Sensing Satellites
by: Abirlal Metya, et al.
Published: (2024-12-01)

Jet Injection of Naked mRNA Encoding the RBD of the SARS-CoV-2 Spike Protein Induces a High Level of a Specific Immune Response in Mice
by: Denis N. Kisakov, et al.
Published: (2025-01-01)

Experience of COVID-19 vaccination among healthcare workers in Iran: a descriptive phenomenological study
by: Atefeh Torknejad, et al.
Published: (2025-01-01)

An Overview on the Role of Relative Humidity in Airborne Transmission of SARS-CoV-2 in Indoor Environments
by: Ajit Ahlawat, et al.
Published: (2020-07-01)

Antivirals for the treatment of mild and moderate COVID-19 in South Africa
by: R Perumal, et al.
Published: (2023-12-01)

An environmental study of tracheostomy on eight COVID-19 patients
by: Kai Xu, et al.
Published: (2021-01-01)

Safety and efficacy of oral administrated cepharanthine in non-hospitalized, asymptomatic or mild COVID-19 patients: a Double-blind, randomized, placebo-controlled trial
by: Jianyi Wei, et al.
Published: (2025-01-01)

The evolving landscape of COVID-19: factors associated with in-hospital COVID-19 related mortality during the 2023–2024 phase of JN.1 subvariant dominance
by: Drieda Zaçe, et al.
Published: (2025-01-01)

From dyspnea to Olympic qualification - A case report as a model for post-acute sequelae of COVID-19
by: Baudrexl JC, et al.
Published: (2025-01-01)

Fc-binding nanodisc restores antiviral efficacy of antibodies with reduced neutralizing effects against evolving SARS-CoV-2 variants
by: Jaehyeon Hwang, et al.
Published: (2025-01-01)

Antibody Responses to mRNA COVID-19 Vaccine Among Healthcare Workers in Outpatient Clinics in Japan
by: Teruhime Otoguro, et al.
Published: (2025-01-01)

Reflections on COVID-19: A Literature Review of SARS-CoV-2 Testing
by: Chin Shern Lau, et al.
Published: (2024-12-01)

Clinical and radiological characteristics and 1-year self-reported outcomes from patients with encephalitis and coronavirus disease 2019
by: Nathane Braga da Silva Rezende, et al.
Published: (2025-01-01)

Activity of Various Cathepsin Proteases and Enrichment of Klotho Protein in the Urine and Urinary Extracellular Vesicles After SARS-CoV-2 Infection
by: Niharika Bala, et al.
Published: (2024-12-01)

Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV)Research in context
by: Podjanee Jittamala, et al.
Published: (2025-02-01)

Metal Complexes and Their Potential Therapeutic Role Against COVID-19: Recent Developments in Drug Designing
by: Kanwal Ashiq, et al.
Published: (2021-12-01)

COVID-19 infection: neurological symptoms and encephalitis
by: A. Jasionis, et al.
Published: (2020-06-01)

Psychosis as an Isolated Manifestation of COVID-19 in Non-Demented Patients with Parkinson's Disease: Clinical Cases and Literature Review
by: G. Lokominaitė, et al.
Published: (2023-11-01)

Vaccination Against SARS-Cov-2 among Patients with Parkinson’s Disease Based on the Results of COVPARK-LT Study
by: R. Kaladytė Lokominienė, et al.
Published: (2024-02-01)

Simulations of pH and thermal effects on SARS-CoV-2 spike glycoprotein
by: Ziyuan Niu, et al.
Published: (2025-02-01)

Newcastle Disease Virus Displaying an Ectodomain of Middle East Respiratory Syndrome Coronavirus Spike Protein Elicited Robust Humoral and Cellular Immunity in Mice
by: Jaturawitt Prasopsiri, et al.
Published: (2024-12-01)

Safety, reactogenicity, and immunogenicity of Ad26.COV2.S co-administered with a quadrivalent standard-dose or high-dose seasonal influenza vaccine: a non-inferiority randomised controlled trialResearch in context
by: Gabriela Tapia-Calle, et al.
Published: (2025-01-01)

Seroprevalence against SARS-CoV-2 after booster vaccination in a prison in Alicante (Spain)
by: Ana C. Montagud, et al.
Published: (2025-01-01)

Effect of Fusion to the LTB Carrier Protein on Coronavirus Spike Protein Vaccine Candidates Produced in Maize
by: Erin Egelkrout, et al.
Published: (2024-12-01)

COVID-19 Symptomatology from the Otorhinolaryngology Perspective: Survey from Tertiary Care Center
by: Raj Tajamul Hussain, et al.
Published: (2023-09-01)

Vascular endothelial growth factor A: friend or foe in the pathogenesis of HIV and SARS-CoV-2 infections?
by: Mieke A. van der Mescht, et al.
Published: (2025-02-01)

Early COVID-19 and protection from Omicron in a highly vaccinated population in Ontario, Canada: a matched prospective cohort study
by: Altynay Shigayeva, et al.
Published: (2025-02-01)